Ustekinumab for the treatment of psoriatic arthritis.

about

Patient considerations and targeted therapies in the management of psoriasis in Chinese patients: role of ustekinumab.The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.

P2860

Q33800651-437FCD58-7ECC-4529-9F94-409704456A61 Q36249305-C4734E06-798D-4F7F-B5B2-FE02E65F7691 Q38250103-5E2CA4C3-66CF-419D-B02E-4A69D28E688A

P2860

Ustekinumab for the treatment of psoriatic arthritis.

Item

http://www.wikidata.org/entity/Q38177336

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Ustekinumab for the treatment of psoriatic arthritis.

@en

type

Item

label

Ustekinumab for the treatment of psoriatic arthritis.

@en

prefLabel

Ustekinumab for the treatment of psoriatic arthritis.

@en

P1476

Ustekinumab for the treatment of psoriatic arthritis.

@en

P2093

Alan Menter

http://www.w3.org/2001/XMLSchema#string

Jay Wofford

http://www.w3.org/2001/XMLSchema#string

P2860

A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R

Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab

Ustekinumab

Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Interleukin-12 and the regulation of innate resistance and adaptive immunity

Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.

Diagnosis and management of psoriatic arthritis.

Current concepts in psoriatic arthritis.

Prevalence of joint disease in patients with psoriasis: implications for therapy.

P304

189-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/1744666X.2014.878649

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24410536

http://www.w3.org/2001/XMLSchema#string

Ustekinumab for the treatment of psoriatic arthritis.

about

P2860

P2860

Ustekinumab for the treatment of psoriatic arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698